Corrigendum to "Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs" [Biochem. Pharmacol. 186 (2021) 114491].

Hammoud SH, AlZaim I, Mougharbil N, Koubar S, Eid AH, Eid AA, El-Yazbi AF

Open source

DOI
10.1016/j.bcp.2023.115420
Published
2023 Apr
Container
Biochemical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2023.115420,
  title = {Corrigendum to "Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs" [Biochem. Pharmacol. 186 (2021) 114491].},
  author = {Hammoud SH and AlZaim I and Mougharbil N and Koubar S and Eid AH and Eid AA and El-Yazbi AF},
  year = {2023},
  journal = {Biochemical pharmacology},
  doi = {10.1016/j.bcp.2023.115420},
  url = {https://doi.org/10.1016/j.bcp.2023.115420}
}

RIS

TY  - JOUR
TI  - Corrigendum to "Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs" [Biochem. Pharmacol. 186 (2021) 114491].
AU  - Hammoud SH
AU  - AlZaim I
AU  - Mougharbil N
AU  - Koubar S
AU  - Eid AH
AU  - Eid AA
AU  - El-Yazbi AF
PY  - 2023
JO  - Biochemical pharmacology
DO  - 10.1016/j.bcp.2023.115420
UR  - https://doi.org/10.1016/j.bcp.2023.115420
ER  - 

APA

SH, H., I, A., N, M., S, K., AH, E., AA, E., & AF, E. (2023). Corrigendum to "Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs" [Biochem. Pharmacol. 186 (2021) 114491].. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2023.115420

Source records